Centers for Disease Control 

National Institute for Occupational Safety and Health 

Advisory Board on Radiation and Worker Health (ABRWH) 

Subcommittee for Procedures Review

Tuesday, February 15, 2022

Summary Proceedings

The Subcommittee for Procedure Reviews meeting convened via teleconference at 11:00 a.m. Eastern 

Time, Josie Beach, Chair, presiding.

Attendees

Members

Rashaun Roberts, Designated Federal Official

Josie Beach, Chair

Loretta R. Valerio, Member

Paul L. Ziemer, Member

Non-Members, Registered and/or Public Comment Participants: 

Nancy Adams, NIOSH Contractor

Dave Allen, DCAS

Bob Anigstein, SC&A

Bob Barton, SC&A

Kathy Behling, SC&A

Fin Black, SC&A

Ron Buchanan, SC&A

Grady Calhoun, DCAS

John Cardarelli, DCAS

Rose Gogliotti, SC&A

Lara Hughes, DCAS

Alek Kranbuhl, DCAS

Lori Marion-Moss, DCAS

Robert McGolerick, HHS

Michael Rafky, HHS

Lavon Rutherford, DCAS

Tim Taulbee, DCAS

Rutherford, Lavon, NIOSH ORAU

Sisko, Jeannie

Taulbee, Tim, NIOSH ORAU

Vinson, Kathleen
Roll Call/Welcome - Dr. Rashaun Roberts, DFO

Dr. Rashaun Roberts called to order the Subcommittee for Procedures Review at 11:00 am on February 

15, 2022, via teleconference. A roll call of all Subcommittee members confirmed that a quorum was present. 

The quorum was maintained throughout the meeting. Dr. Roberts reviewed subcommittee members’ 

conflicts of interests with respect to covered facilities. There were no conflicts with respect to the documents 

on today’s agenda. Dr. Roberts turned the meeting over to Ms. Beach, Subcommittee Chair.

Carry Over Items from Feb. 13, 2019, Feb. 18, 2021, & Nov. 3, 2021 

SPR Meetings

ORAUT-OTIB-0006, “Dose Reconstruction for Occupational Medical X-ray 

Procedures”

Ron Buchanan presented SC&A’s update on the review of this document. DCAS issued Rev. 6 of 

the subject document, in part, to address 7 observations from SC&A’s review of Rev. 5. The 

Subcommittee had closed 5 of the observations at its February 2021 meeting. DCAS and SC&A 

exchanged information after that meeting and based on that SC&A recommended closing the two 

remaining observations. The Subcommittee agreed and closed the observations.

ORAUT-OTIB-0011, “Tritium Calculated and Missed Dose Estimates”

Ron Buchanan, SC&A, reported that any findings and observations related to this document had 

been closed previously. After discussion among the Subcommittee, SC&A, and DCAS, the 

Subcommittee decided that the necessary action was to include closure discussions in the “Board 

Review System (BRS) matrix”. Information in the BRS matrix will then be added to the application 

that succeeds the BRS when the Cybersecurity Update Initiative is completed.

ORAUT-OTIB-0001 “Maximum Internal Dose Estimates for Savannah River Site 

(SRS) Claims”

Kathy Behling, SC&A, led the discussion of this document. OTIB-0011 was cancelled years ago 

and was replaced, at least in part, by OTIB-0018. One finding that was recorded as an OTIB-0001 

finding really pertains to OTIB-0018. The Subcommittee, SC&A, and DCAS have discussed the 

finding, but it has not been closed. The Subcommittee decided to transfer the finding from OTIB0001 to OTIB-0018 and keep it in progress. DCAS is revising OTIB-0018, so the Subcommittee will 

revisit this finding when the OTIB-0018 revision is published.

ORAUT-TKBS-0060, “Site Profile for Grand Junction Facilities”

Alek Kranbuhl, DCAS, presented DCAS’s response to five observations from SC&A’s review of this 

document. DCAS agreed to revise TKBS-0060 in response to Observations 1 and 2. SC&A and 

the Subcommittee agreed with the proposed revisions, so those observations were placed in 

abeyance. For Observation 3, DCAS will provide SC&A access to a worker interview about the 

operation of the radon calibration chamber and the operating procedure for that chamber. That 

observation is in progress. DCAS and SC&A will evaluate Observations 4 and 5 further. Those 

observations are also in progress.
DCAS-PER-087, “Clarksville and Medina Modification Centers”

Tim Taulbee, DCAS, provided an update on DCAS’s efforts to respond to Finding 1. DCAS must 

acquire additional dosimetry information from Sandia National Laboratory in order to complete its 

investigation. The finding remains in progress. DCAS agreed with Observation 1 and agreed to 

clarify language in the PER. That observation is in abeyance. Kathy Behling, SC&A, pointed out 

that Finding 1 for PER-087 was a restatement of Finding 7 from SC&A’s review of the 

Clarksville/Medina TBD. After discussion, the Subcommittee, SC&A, and DCAS agreed it would be 

easier to track progress on this item under the Clarksville/Medina TBD. For that reason, the 

Subcommittee closed the discussion of PER-087. The Subcommittee will continue to track the 

finding under the Clarksville/Medina TBD.

ORAUT-OTIB-0088, “External Dose Reconstruction”

Ron Buchanan, SC&A, described the results of SC&A’s review of Rev 2 of the subject document. 

SC&A’s review focused on determining if Rev 2 had addressed 5 observations that resulted from 

SC&A’s review of Rev 1. Tim Taulbee, DCAS, described DCAS’s continuing efforts on OTI-0088, 

and suggested that the Subcommittee make these changes in observation status:

• Change Observations 3’s status from closed to in abeyance

• Change Observations 4’s status from in abeyance to in progress

• Keep Observation 5’s status as in abeyance

The Subcommittee agreed with those recommendations.

Newly-issued SC&A Reviews

Battelle-TIB-5000 “Default Assumptions and Methods for Atomic Weapons 

Employer Dose Reconstructions”

Dr. Robert Anigstein, SC&A, presented the results of SC&A’s review of Battelle-TIB-5000, SC&A 

developed 13 observations during their review. This document was published in 2007, and SC&A 

acknowledged that DCAS might not be using its information anymore. After Dr. Anigstein’s 

presentation, Dr. Tim Taulbee, DCAS, confirmed that DCAS no longer used much of the guidance 

in Battelle-TIB-5000. DCAS is considering cancelling it but is reviewing it to determine that any 

guidance currently being used has been incorporated into later documents. The Subcommittee 

considers these observations in progress until it receives additional information from DCAS.
DCAS-PER-045, Subtask 4 “Aliquippa Forge TBD Revision” case review

Kathy Behling, SC&A, described the history of revisions to the Aliquippa Forge TBD, and PER-045, 

which was generated by Rev 1. At the time SC&A was tasked to review PER-045, they had not 

reviewed the Aliquippa Forge TBD, so a review of Rev 1 of that document was included in the PER045 review. The review of Rev 1 of the TBD resulted in 8 findings and 2 observations. The 

Subcommittee discussed Rev 2 of the TBD at its May 2016 meeting and agreed to close some of 

the findings at that time.

The object of SC&A’s presentation at this meeting was the case review from PER-045. After

reviewing a PER document itself, SC&A then reviews a selection of claims that were re-worked 

because of the PER. The number of claims they review can vary from one to several. The objective 

is to find a claim or set of claims that include all the technical changes that gave rise to the PER. 

For PER-045, SC&A reviewed the dose reconstruction for one claim. That review did not result in 

any findings or observations, and the Subcommittee agreed with that result. Due to time constrains, 

the Chair decided to carry PER-052, PER-0059, and PER-0062 over until the next Subcommittee 

meeting. Preparation for Full Board Meeting: Review of Technical Guidance Documents Ready for 

Full Board Review. Due to time constrains, the Chair decided to carry PER-052, PER-0059, and 

PER-0062 over until the next Subcommittee meeting.

Preparation for Full Board Meeting: Review of Technical Guidance 

Documents Ready for Full Board Review

The Subcommittee decided to present several documents at the next Board meeting. The Subcommittee 

has completed its discussion on these documents, but it has not yet presented them to the full Board for 

concurrence.

Newly-issued Guidance Documents and Supplemental topics

The Subcommittee tasked SC&A to review the following documents:

ORAUT-RPRT-0097, rev. 00, “Breathing Zone to General Area Air Concentration Ratios in Small 

Workrooms”

DCAS-PER-092, rev. 0, “Weldon Spring Plant”

DCAS-PER-093, rev. 0, “Texas City Chemicals, TBD Rev.01”

SC&A proposed several changes that would improve the functionality of the Board Review System (BRS). 

These changes will be considered during the development of the application that will succeed the BRS.

SC&A requested that they be added to notifications of cancelled documents, revised documents, and new 

documents. DCAS agreed to do that.

SC&A requested similar notification about issuance and changes to Dose Reconstruction Templates. 

DCAS provided a list of Dose Reconstruction Templates in 2018, and re-sent it to SC&A. That list will be 

discussed at the next Subcontractor meeting.

SC&A suggested that the successor to the BRS include information from the full Board discussion of 

documents that the Subcommittee presents.
SC&A noted that there have been findings that were closed when they should have been placed in 

abeyance. When the BRS successor application is available, the Subcommittee will revisit the findings that 

SC&A has identified.

SC&A also noted that the BRS successor should have a method for capturing Board discussion and 

questions, so that the Subcommittee can follow-up and get back to the Board.

SC&A has reviewed the transcripts of all Board meetings where the Subcommittee recommended closing 

document reviews. They have captured any comments Board members made at those meetings. The 

collection of comments will be provided to the Subcommittee members.

Next Meeting/Plans

The Subcommittee decided to plan the next meeting and specify any additional SC&A tasking via email.

Meeting Adjourned

The Subcommittee adjourned the meeting at 3:41 pm.